Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Akt1


Brief Information

Name:Serine/threonine-protein kinase AKT1
Target Synonym:EC:,EC 2.7.11,Proto-oncogene c-Akt,Protein kinase B,RAC,RAC-PK-alpha,PKB alpha,RAC-alpha serine/threonine-protein kinase,AKT1,AKT Serine/Threonine Kinase 1,V-Akt Murine Thymoma Viral Oncogene Homolog 1,Protein Kinase B Alpha,PKB,V-Akt Murine Thymoma Viral Oncogene-Like Protein 1,Serine-Threonine Protein Kinase,Rac Protein Kinase Alpha,EC,PKB-ALPHA,RAC-ALPHA,AKT1m,PRKBA,CWS6,AKT
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:19
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
AK1-H5283 Human Human Akt1 Protein, His,Strep II Tag
ACRO Quality

Synonym Name

AKT1,PKB,RAC,RAC-PK-alpha,PKB alpha


RAC-alpha serine/threonine-protein kinase (AKT1) is also known PKB, Protein kinase B alpha, PKB alpha, Proto-oncogene c-Akt and RAC-PK-alpha, which belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family and RAC subfamily and is expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase).

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Capivasertib AZD-5363 Approved Astex Pharmaceuticals Inc, Cancer Research Technology, The Institute Of Cancer Research, London Truqap United States Breast Neoplasms Astrazeneca Pharmaceuticals Lp 2023-11-16 Uterine Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Metastatic breast cancer; Thyroid Neoplasms; Lung Neoplasms; Prostatic Neoplasms, Castration-Resistant; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Endometrial Neoplasms; Lymphoma; HR-positive breast cancer; Glioma; Uterine Cervical Neoplasms; Melanoma; Squamous Cell Carcinoma of Head and Neck; Hematologic Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Liver Neoplasms; Rectal Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Stomach Neoplasms; Solid tumours; Colonic Neoplasms; Triple Negative Breast Neoplasms; Skin Neoplasms; Carcinoma, Ovarian Epithelial; Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Multiple Myeloma Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Afuresertib ASB-183; GSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002 Phase 3 Clinical Glaxosmithkline Plc, Novartis Pharma Ag Breast Neoplasms; Adenocarcinoma; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Metastatic breast cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Multiple Myeloma; Triple Negative Breast Neoplasms; Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Solid tumours; Ovarian Neoplasms Details
Ipatasertib Dihydrochloride RG-7440; GCD-0068; GDC-0068; RO-5532961 Phase 3 Clinical Array Biopharma, F. Hoffmann-La Roche Ltd Paranasal Sinus Neoplasms; Hepatic Insufficiency; Urogenital Neoplasms; Neoplasms, Unknown Primary; Endometrial Neoplasms; Carcinoma, Squamous Cell; Lip Neoplasms; Laryngeal Neoplasms; Mouth Neoplasms; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Paranasal Sinus Diseases; Uterine Neoplasms; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid; Adenocarcinoma; Glioblastoma; Solid tumours; Neoplasm, Residual; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Cystadenocarcinoma, Serous; Triple Negative Breast Neoplasms; Neoplasms; Ovarian Neoplasms; Hypopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Genital Neoplasms, Female; Oropharyngeal Neoplasms Details
TIC-10 ONC201 - Oncoceutics; ONC201/TIC10; NSC-350625; TIC-10; ONC-201 Phase 3 Clinical Oncoceutics Inc Diffuse Intrinsic Pontine Glioma; Central Nervous System Lymphoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Meningioma; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Adenomatous Polyps; Endometrial Neoplasms; Glioma; Gliosarcoma; Colorectal Neoplasms; Adenomatous Polyposis Coli; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Breast Neoplasms; Multiple Myeloma; Neoplasms; Myelodysplastic Syndromes; Triple Negative Breast Neoplasms; Thalamic Diseases; Glioblastoma; Diffuse midline glioma; Solid tumours Details
Triciribine Phosphate NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 Phase 2 Clinical National Cancer Institute Ovarian Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Breast Neoplasms Details
Miransertib MK-7075; ARQ-092 Phase 2 Clinical Arqule Inc Proteus Infections; Solid tumours; Ovarian Neoplasms; Neoplasms; PIK3CA-Related Overgrowth Spectrum; Proteus Syndrome; Lymphoma; Endometrial Neoplasms Details
Iopofosine I-131 CLR-131; NM404; (131)I-CLR1404; 131I-NM-404; HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404 Phase 2 Clinical University Of Michigan Neuroblastoma; Central Nervous System Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Glioma; Waldenstrom Macroglobulinemia; Diffuse Intrinsic Pontine Glioma; Sarcoma, Ewing; Brain Neoplasms; Lymphoma, B-Cell, Marginal Zone; Osteosarcoma; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Rhabdomyosarcoma; Solid tumours; Head and Neck Neoplasms Details
Uprosertib/Trametinib Dimethyl Sulfoxide Phase 2 Clinical Novartis Pharma Ag Leukemia, Myeloid, Acute; Endometrial Neoplasms; Uterine Cervical Neoplasms Details
TAS-117 TAS-117 Phase 2 Clinical Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd Solid tumours Details
Selumetinib sulfate/MK-2206 Phase 2 Clinical Astrazeneca Plc, Merck & Co Inc Rectal Neoplasms; Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
Uprosertib GSK-795; GSK-2141795; GSK-2141795C; UPB-795 Phase 2 Clinical Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute Solid tumours; Hematologic Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Multiple Myeloma; Breast Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Uterine Neoplasms; Endometrial Neoplasms; Uterine Cervical Neoplasms; Melanoma; Adenocarcinoma Details
RX-0301 RX-0301; WGI-0301; RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N; RX-0201改良型; HC0301 Phase 2 Clinical Rexahn Pharmaceuticals Inc Liver Neoplasms; Solid tumours; Carcinoma, Hepatocellular Details
MK-2206 NSC-749607; BIND-2206; MK2206; MK-2206 Phase 2 Clinical Merck Sharp & Dohme Corp Leukemia, Myelomonocytic, Juvenile; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Neoplasms, Gonadal Tissue; Gallbladder Neoplasms; Burkitt Lymphoma; Endometrial Neoplasms; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia; Lymphoma; Leukemia, Monocytic, Acute; Glioma; Peritoneal Neoplasms; Adenocarcinoma, Bronchiolo-Alveolar; Colorectal Neoplasms; Sezary Syndrome; Leukemia, Myeloid, Chronic-Phase; Bile Duct Neoplasms; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lymphoproliferative Disorders; Cholangiocarcinoma; Carcinoma, Adenosquamous; Adenocarcinoma; Breast Neoplasms, Male; Mycosis Fungoides; Melanoma; Leukemia, Prolymphocytic; Leukemia, T-Cell; Carcinoma, Non-Small-Cell Lung; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Central Nervous System Lymphoma; Carcinoma, Hepatocellular; Breast Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, Large-Cell, Anaplastic; Adenocarcinoma, Mucinous; Thymoma; Lung Neoplasms; Leukemia, Myeloid, Acute; Fallopian Tube Neop Details
NTQ-1062 NTQ-1062; NTQ1062 Phase 2 Clinical Nanjing Zhengda Tianqing Pharmaceutical Co Ltd Solid tumours; Breast Neoplasms; HR-positive breast cancer Details
HZB-0071 HZB-0071 Phase 1 Clinical Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd Neoplasms Details
Rupitasertib DIACC3010; M-2698; MSC-2363318A; DIACC-3010 Phase 1 Clinical Emd Serono Inc Solid tumours; Stomach Neoplasms; Glioblastoma; Breast Neoplasms Details
Honokiol HU-002; JRF-101 Phase 1 Clinical Anacor Pharmaceuticals Inc Metabolic Dysfunction-Associated Steatotic Liver Disease; Gingival Diseases; Carcinoma, Non-Small-Cell Lung Details
CMX-2043 LIP-EA; CMX-2043; R-LIP-EA-OH Phase 1 Clinical Ischemix Llc Brain Injuries, Traumatic; Angina, Unstable; Coronary Artery Disease Details
Hu-7691 Hu-7691 Phase 1 Clinical Zhejiang University Solid tumours; Neoplasms Details
Oxysterols (Intsel Chimos) Clinical Centre National De La Recherche Scientifique (Cnrs) Glioma Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message